跳至主要内容
临床试验/NCT01244204
NCT01244204已完成不适用

Vitamin D Supplementations as Adjunct to Anti-tuberculosis Drugs in Mongolia

Harvard School of Public Health (HSPH)0 个研究点目标入组 120 人开始时间: 2009年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
主要终点
Serum vitamin D levels

研究概览

简要总结

The investigators proposed a pilot study preparatory to developing a randomized trial of vitamin D for the prevention of TB infection. The specific aims are presented below:

  1. To recruit subjects, obtain consent, distribute vitamin D supplements to the children in the schools, obtain blood samples and transport them to the United States.
  2. To test the hypothesis that daily vitamin D supplementation will increase plasma levels of 25(OH)D, and restore TLR-induced antimicrobial activity in monocytes/macrophages tested in vitro.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Eligible subjects will be children age 12 to 15 years inclusive in public school, located in Songino-Khairhan district, who are residents of Ulaanbaatar, and whose parents have given informed consent and who accent to participate in the study.

排除标准

  • Individuals with pre-existing calcium, parathyroid conditions, or type I diabetes, sarcoidosis, or who require chronic diuretic therapy including calcium channel blockers, or who are cognitively impaired.

结局指标

主要结局

Serum vitamin D levels

时间窗: 6 months

Tuberculin Skin Test conversion

时间窗: 6 monhs

次要结局

未报告次要终点

研究者

发起方
Harvard School of Public Health (HSPH)
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ganmaa Davaasambuu

Assistant Professor of Medicine

Harvard School of Public Health (HSPH)

相似试验

Role of Vitamin D in Innate Immunity to Tuberculosis | 临床试验